Thomas E. Gardner Named President/CEO at EuroMed

New leadership to help guide partnership agreements and expand product development

ORANGEBURG, N.Y.–(BUSINESS WIRE)–EuroMed Inc. today announced the appointment of Thomas E. Gardner as president and chief executive officer. In his new role, Gardner will work to accelerate the development and commercialization of novel hydrocolloid products to benefit the wound care industry. He also will promote the growth and enduring economic value of the company for its shareholders through strategic initiatives. EuroMed is a leading designer and manufacturer of wound care management products, and one of a select few custom hydrocolloid manufacturers providing comprehensive private labeling services.

Robert Jensen, EuroMed’s senior Board member said, “Tom Gardner will be a critical asset to EuroMed in that he is a specialist in the strategic positioning of companies, with particular emphasis on consumer and specialty pharmaceuticals as well as medical devices.

“Considering his extensive experience in these areas,” Jensen continued, “Mr. Gardner will have a meaningful impact on EuroMed’s efforts to strengthen its existing partnerships and to develop new ones both domestically and internationally. We look forward to the contributions he will make on behalf of our company.”

Prior to joining EuroMed, Gardner was CEO of a number of public and private companies including NUCRYST Pharmaceuticals (sold to Smith & Nephew), Songbird Hearing (sold controlling interest to a major consumer packaged goods company), Datamonitor (IPO on London Stock Exchange), Base Ten Systems (assets purchased by Smiths Aerospace and ABB Group), and Access Health (now McKesson Health Solutions). He also held marketing and general management positions at Procter & Gamble, Johnson & Johnson, Simon & Schuster and IMS Health.

Gardner received a B.A. in Economics and Mathematics from the University of St. Thomas in Minnesota and has been a guest lecturer at Northwestern University’s Kellogg Graduate School of Management. He is a resident of Princeton, N.J.